NI201000110A - Derivados bicíclicos para usar en el tratamiento de afecciones asociadas con el receptor de andrógeno. - Google Patents
Derivados bicíclicos para usar en el tratamiento de afecciones asociadas con el receptor de andrógeno.Info
- Publication number
- NI201000110A NI201000110A NI201000110A NI201000110A NI201000110A NI 201000110 A NI201000110 A NI 201000110A NI 201000110 A NI201000110 A NI 201000110A NI 201000110 A NI201000110 A NI 201000110A NI 201000110 A NI201000110 A NI 201000110A
- Authority
- NI
- Nicaragua
- Prior art keywords
- treatment
- conditions associated
- androgen receptor
- bicyclic derivatives
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a los compuestos bicíclicos de Fórmula I donde los números enteros X1, X2, X3, el Anillo A, R4, R5 y m son como los definidos en la descripción. La presente invención también se relaciona con procesos para la preparación de tales compuestos, composiciones farmacéuticas que los contienen y su uso en la fabricación de un medicamento para su uso en la prevención o tratamiento de afecciones asociadas con el receptor de andrógeno.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1575507P | 2007-12-21 | 2007-12-21 | |
US9609008P | 2008-09-11 | 2008-09-11 | |
US10780408P | 2008-10-23 | 2008-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
NI201000110A true NI201000110A (es) | 2012-05-14 |
Family
ID=40428336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NI201000110A NI201000110A (es) | 2007-12-21 | 2010-06-21 | Derivados bicíclicos para usar en el tratamiento de afecciones asociadas con el receptor de andrógeno. |
Country Status (23)
Country | Link |
---|---|
US (1) | US8003649B2 (es) |
EP (1) | EP2235010A1 (es) |
JP (1) | JP2011507824A (es) |
KR (1) | KR20100099742A (es) |
CN (1) | CN101952286A (es) |
AR (1) | AR069911A1 (es) |
AU (1) | AU2008339572B2 (es) |
BR (1) | BRPI0821676A2 (es) |
CA (1) | CA2709514A1 (es) |
CL (1) | CL2008003846A1 (es) |
CO (1) | CO6331441A2 (es) |
CR (1) | CR11524A (es) |
DO (1) | DOP2010000195A (es) |
EA (1) | EA017144B1 (es) |
EC (1) | ECSP10010291A (es) |
IL (1) | IL206284A0 (es) |
NI (1) | NI201000110A (es) |
NZ (1) | NZ586913A (es) |
PE (1) | PE20091157A1 (es) |
TW (1) | TW200927121A (es) |
UY (1) | UY31559A1 (es) |
WO (1) | WO2009081197A1 (es) |
ZA (1) | ZA201004227B (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008013791A2 (en) * | 2006-07-24 | 2008-01-31 | University Of Delaware | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
US8188083B2 (en) * | 2007-06-28 | 2012-05-29 | Abbott Laboratories | Triazolopyridazines |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
US8268872B2 (en) | 2008-02-22 | 2012-09-18 | Radius Health, Inc. | Selective androgen receptor modulators |
WO2009105214A2 (en) | 2008-02-22 | 2009-08-27 | Radius Health, Inc. | Selective androgen receptor modulators |
DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
UA103646C2 (ru) | 2008-12-22 | 2013-11-11 | Мерк Патент Гмбх | Полиморфные формы 6-(1-метил-1h-пиразол-4-ил)-2-{3-[5-(2-морфолин-4-илетокси)-пиримидин-2-ил]-бензил}-2h-пиридазин-3-она и способ их получения (варианты) |
WO2010092371A1 (en) * | 2009-02-10 | 2010-08-19 | Astrazeneca Ab | Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer |
US20100292222A1 (en) * | 2009-05-11 | 2010-11-18 | Astrazeneca Ab | Chemical compounds 751 |
WO2011008543A2 (en) * | 2009-06-29 | 2011-01-20 | University Of Delaware | Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
JP5848251B2 (ja) | 2009-10-23 | 2016-01-27 | ヤンセン ファーマシューティカ エヌ.ベー. | オレキシン受容体調節因子としての縮合複素環式化合物 |
JP5759470B2 (ja) | 2009-10-23 | 2015-08-05 | ヤンセン ファーマシューティカ エヌ.ベー. | オレキシン受容体調節因子としての二置換オクタヒドロピロロ[3,4−c]ピロール |
EP2491034B1 (en) | 2009-10-23 | 2013-12-18 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as orexin receptor modulators |
WO2011082271A2 (en) | 2009-12-30 | 2011-07-07 | Arqule, Inc. | Substituted triazolo-pyrimidine compounds |
JP5964756B2 (ja) | 2010-02-04 | 2016-08-03 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
LT2568806T (lt) | 2010-05-12 | 2016-09-26 | Radius Health, Inc. | Terapiniai režimai |
BR112012029026A2 (pt) | 2010-05-13 | 2016-08-02 | Amgen Inc | composto heretocíclicos de nitrogênio úteis como inbidores pde10 |
US9006450B2 (en) | 2010-07-01 | 2015-04-14 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
US8642632B2 (en) | 2010-07-02 | 2014-02-04 | Radius Health, Inc. | Selective androgen receptor modulators |
JP5965909B2 (ja) | 2010-09-28 | 2016-08-10 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
WO2012145581A1 (en) | 2011-04-20 | 2012-10-26 | Janssen Pharmaceutica Nv | Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
US9175291B2 (en) | 2012-10-11 | 2015-11-03 | Isis Pharmaceuticals Inc. | Modulation of androgen receptor expression |
US9422290B2 (en) * | 2012-11-13 | 2016-08-23 | Boehringer Ingelheim International Gmbh | Triazolopyridazine |
US9266891B2 (en) | 2012-11-16 | 2016-02-23 | Boehringer Ingelheim International Gmbh | Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors |
HUP1300139A2 (en) * | 2013-03-06 | 2014-09-29 | Richter Gedeon Nyrt | Phenoxypiperidine h3 antagonists |
CA2912683A1 (en) | 2013-05-13 | 2014-11-20 | Glaxosmithkline Llc | Substituted bridged urea analogs as sirtuin modulators |
BR112015030248A2 (pt) * | 2013-06-10 | 2017-07-25 | Astellas Pharma Inc | composto de amida heterocíclica aromática contendo nitrogênio bicíclico |
NO2719005T3 (es) | 2014-07-28 | 2018-01-20 | ||
EP3034499A1 (en) * | 2014-12-17 | 2016-06-22 | Gilead Sciences, Inc. | Novel FXR (NR1H4) modulating compounds |
EP3034501A1 (en) * | 2014-12-17 | 2016-06-22 | Gilead Sciences, Inc. | Hydroxy containing FXR (NR1H4) modulating compounds |
EP3285764B1 (en) * | 2015-03-31 | 2024-03-27 | University of Vermont and State Agricultural College | Triazolopyridazines for treating cryptosporidiosis |
KR102559922B1 (ko) | 2016-03-10 | 2023-07-25 | 얀센 파마슈티카 엔.브이. | 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법 |
ES2921432T3 (es) | 2016-06-13 | 2022-08-25 | Gilead Sciences Inc | Derivados de azetidina como moduladores de FXR (NR1H4) |
CA2968836A1 (en) | 2016-06-13 | 2017-12-13 | Gilead Sciences, Inc. | Fxr (nr1h4) modulating compounds |
KR102397890B1 (ko) | 2016-06-22 | 2022-05-12 | 일립시스 파마 리미티드 | Ar+ 유방암 치료 방법 |
ES2927019T3 (es) | 2017-03-28 | 2022-11-02 | Gilead Sciences Inc | Combinaciones terapéuticas para el tratamiento de enfermedades hepáticas |
KR20200036913A (ko) * | 2017-08-04 | 2020-04-07 | 브리스톨-마이어스 스큅 컴퍼니 | [1,2,4]트리아졸로[4,3-a]피리디닐 치환된 인돌 화합물 |
GB201716871D0 (en) * | 2017-10-13 | 2017-11-29 | Inst Of Cancer Research: Royal Cancer Hospital | Compounds |
GB201806663D0 (en) * | 2018-04-24 | 2018-06-06 | Avexxin As | 2-Oxothiazole compositions for treatment of fibrotic disease |
US20220062278A1 (en) * | 2018-12-11 | 2022-03-03 | Arizona Board Of Regents On Behalf Of The Univeristy Of Arizona | Small molecule inhibitors of the androgen receptor activity and/or expression and uses thereof |
CN109942574B (zh) * | 2019-01-11 | 2022-04-01 | 成都阿奇生物医药科技有限公司 | 天奇替尼及其制备方法和用途 |
DK3911647T3 (da) | 2019-01-15 | 2024-02-26 | Gilead Sciences Inc | Isoxazol-forbindelse som FXR-agonist og farmaceutiske sammensætninger, der omfatter en sådan |
CN113439078B (zh) | 2019-02-19 | 2024-04-23 | 吉利德科学公司 | Fxr激动剂的固体形式 |
JP7434265B2 (ja) * | 2020-12-30 | 2024-02-20 | 財團法人工業技術研究院 | アンドロゲン受容体結合分子およびその使用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE384048T1 (de) | 1998-09-22 | 2008-02-15 | Astellas Pharma Inc | Cyanophenyl-derivate |
US6184249B1 (en) | 1998-12-18 | 2001-02-06 | Biophysica, Inc. | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
US6472415B1 (en) | 1998-12-18 | 2002-10-29 | Biophysica, Inc. | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
EP1796669B1 (en) * | 2004-10-01 | 2010-09-22 | Merck Sharp & Dohme Corp. | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
WO2008109104A1 (en) * | 2007-03-07 | 2008-09-12 | The Regents Of The University Of California | Bivalent inhibitors of akt protein kinase |
-
2008
- 2008-12-18 NZ NZ586913A patent/NZ586913A/en not_active IP Right Cessation
- 2008-12-18 AU AU2008339572A patent/AU2008339572B2/en not_active Ceased
- 2008-12-18 CA CA2709514A patent/CA2709514A1/en not_active Abandoned
- 2008-12-18 PE PE2008002119A patent/PE20091157A1/es not_active Application Discontinuation
- 2008-12-18 JP JP2010538919A patent/JP2011507824A/ja active Pending
- 2008-12-18 WO PCT/GB2008/051206 patent/WO2009081197A1/en active Application Filing
- 2008-12-18 EA EA201000946A patent/EA017144B1/ru not_active IP Right Cessation
- 2008-12-18 EP EP08863828A patent/EP2235010A1/en not_active Withdrawn
- 2008-12-18 US US12/338,405 patent/US8003649B2/en not_active Expired - Fee Related
- 2008-12-18 KR KR1020107016410A patent/KR20100099742A/ko not_active Application Discontinuation
- 2008-12-18 CN CN200880127073XA patent/CN101952286A/zh active Pending
- 2008-12-18 BR BRPI0821676-2A patent/BRPI0821676A2/pt not_active IP Right Cessation
- 2008-12-19 UY UY31559A patent/UY31559A1/es not_active Application Discontinuation
- 2008-12-19 AR ARP080105584A patent/AR069911A1/es not_active Application Discontinuation
- 2008-12-19 CL CL2008003846A patent/CL2008003846A1/es unknown
- 2008-12-19 TW TW097149898A patent/TW200927121A/zh unknown
-
2010
- 2010-06-10 IL IL206284A patent/IL206284A0/en unknown
- 2010-06-14 ZA ZA2010/04227A patent/ZA201004227B/en unknown
- 2010-06-21 DO DO2010000195A patent/DOP2010000195A/es unknown
- 2010-06-21 CO CO10074454A patent/CO6331441A2/es not_active Application Discontinuation
- 2010-06-21 NI NI201000110A patent/NI201000110A/es unknown
- 2010-06-21 EC EC2010010291A patent/ECSP10010291A/es unknown
- 2010-06-21 CR CR11524A patent/CR11524A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20100016279A1 (en) | 2010-01-21 |
CL2008003846A1 (es) | 2010-02-05 |
ZA201004227B (en) | 2011-10-26 |
KR20100099742A (ko) | 2010-09-13 |
TW200927121A (en) | 2009-07-01 |
BRPI0821676A2 (pt) | 2015-06-16 |
EA017144B1 (ru) | 2012-10-30 |
EA201000946A1 (ru) | 2010-12-30 |
NZ586913A (en) | 2012-06-29 |
CN101952286A (zh) | 2011-01-19 |
AU2008339572A1 (en) | 2009-07-02 |
EP2235010A1 (en) | 2010-10-06 |
CR11524A (es) | 2010-08-05 |
CO6331441A2 (es) | 2011-10-20 |
DOP2010000195A (es) | 2010-08-31 |
AU2008339572B2 (en) | 2012-05-10 |
US8003649B2 (en) | 2011-08-23 |
UY31559A1 (es) | 2009-08-03 |
PE20091157A1 (es) | 2009-09-03 |
WO2009081197A1 (en) | 2009-07-02 |
ECSP10010291A (es) | 2010-07-30 |
AR069911A1 (es) | 2010-03-03 |
IL206284A0 (en) | 2010-12-30 |
CA2709514A1 (en) | 2009-07-02 |
JP2011507824A (ja) | 2011-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201000110A (es) | Derivados bicíclicos para usar en el tratamiento de afecciones asociadas con el receptor de andrógeno. | |
CR11801A (es) | Derivados de indazol sustituidos con fenilo y benzodioxinilo | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
ECSP11011390A (es) | Compuestos espiro-amidas sustituidas | |
ECSP099620A (es) | Derivados de ciclohexano espirociclico | |
CO6470845A2 (es) | Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales | |
ECSP11011517A (es) | Compuestos antivirales | |
ECSP13012519A (es) | Compuestos sustituidos de benzamida | |
DOP2014000012A (es) | Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa | |
CO6470899A2 (es) | 2,4-diaminopirimidinas para el tratamiento de enfermedades caracterizadas por proliferación celular excesiva o normal | |
CR20110255A (es) | Nuevos compuestos 578 | |
UY33817A (es) | ?nuevas oxindolpirimidinas bencílicas?. | |
UY32426A (es) | Derivados bicilicos para uso en el tratamiento de enfermedades relacionadas al receptor de androgeno | |
CL2012001461A1 (es) | Compuestos derivados de difenil-pirazolopiridinas, moduladores del receptor nuclear nurr-1; compuestos intermediarios; composición farmacéutica; y su uso para el tratamiento y prevención de enfermedades neurodegenerativas, traumatismos cerebrales, enfermedades inflamatorias, osteoporosis, cáncer, entre otras. | |
UY31905A (es) | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
PA8806801A1 (es) | Compuestos de amida como refuerzos de antivirales | |
ECSP109961A (es) | Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica | |
UY32623A (es) | Derivados bicíclicos para afecciones asociadas al receptor de andrógenos | |
UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
CL2010001432A1 (es) | Compuestos derivados de 2-oxo-alquil-1-piperazin-2-ona, afines por los receptores p75ntr; procedimiento para preparar los compuestos; compuesto intermediario; medicamento y composicion farmaceutica que comprende a uno de los compuestos; y su uso en la preparacion de medicamentos utiles para tratar enfermedades neurodegenerativas. | |
CU20100129A7 (es) | Derivados bicíclicos para usar en el tratamiento de afecciones asociadas con el receptor de andrógeno | |
CU20100226A7 (es) | Derivados de indazol sustituidos con fenilo y benzodioxinilo |